A survey of hospital laboratory services has demonstrated marked deficiencies in the performance of gastrointestinal function tests. The repertoire of gastrointestinal investigations available varies widely between laboratories and, in general, analyses are performed infrequently. Most laboratories do not perform internal quality control, and inter-laboratory reproducibility of some analytes is very poor. A wide variety of protocols and reference ranges are in use, many of which are unevaluated. Some analytical methods and protocols in current use are outdated, with published improvements not being applied.
INTRODUCTION
When choosing laboratory tests for investigating gastroenterological problems such as diarrhoea, malabsorption and pancreatic dysfunction, it is difficult to determine from the literature which tests are most appropriate. For example, for the investigation of malabsorption, a variety of tests are available: faecal fat measurement, xylose absorption test, fat load test, faecal microscopy, oxalate loading tests and 14C breath tests. To further cloud the choice, several protocols are often described for each method, and published evaluations of gastrointestinal (GI) tests frequently give conflicting reports. In 1993 an audit in South East and North West Thames regions revealed wide variation in usage of, and protocols for, GI tests and questioned the quality of results from infrequently performed tests.' The aim of the present survey was to assess by questionnaire and sample analysis the GI services currently provided by hospital laboratories throughout the UK, with an emphasis on the diversity of tests in use, the analytical quality of results and the variability in protocols and reference ranges. The results provide a framework for beginning to address the deficiencies identified.
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MATERIALS AND METHODS

Questionnaire design
An initial questionnaire and letter was sent to heads of department of 270 clinical biochemistry departments and seven specialized gastroenterology laboratories in 271 hospitals throughout the UK. The questionnaire sought information on the repertoire of Gl tests available, other sites in the hospital performing GI tests, whether samples are sent elsewhere for measurement, whether samples would be welcomed for analytical assessment of various GI tests, and contact names to whom follow-up questionnaires and samples for analysis should be sent.
Nominated contacts were then sent one or more of 19 follow-up questionnaires on specific GI investigations in order to obtain the following information: numbers of tests performed per year, patient preparation, test protocol, method of analysis, reference range quoted, how the reference range was established, internal quality control procedures and other information relevant to the test.
If the responder to the initial questionnaire indicated their agreement to analyse samples, and if the relevant follow-up questionnaire was returned, then sets of samples (usually three, with a result sheet and covering letter), were dispatched for measurement of the following analytes: xylose, fluorescein, p-aminobenzoic acid (PABA) and laxatives in urine; PABA, xylose and fat in plasma; fat, rx-l-antitrypsin and chymotrypsin in faeces; faecal microscopy; trypsin and bicarbonate in duodenal juice; disaccharidase enzymes in intestinal homogenates; and 14C in solution.
A separate questionnaire and covering letter was sent to the 396 UK consultant physicians who are members of the British Society of Gastroenterology. These questionnaires yielded information relating to clinical as well as laboratory aspects; however, only the latter arc considered further here. Follow-up questionnaires on hydrogen and 14C breath tests were sent to nominated contacts.
If questionnaires were not returned within a specified time (6 weeks for the initial laboratory and clinical questionnaires and 3 months for the more comprehensive followup laboratory questionnaires), then reminder letters and duplicate questionnaires were sent. Reminder letters were also sent if results from distributed samples were not returned within 8 weeks.
Some laboratories returned analytical results which were clearly incorrect and, on these occasions, the contact person was telephoned to determine the reason for the likely error. If a mistake had been made then the correct result was substituted and a note made of the reason for the error.
Preparation of samples for analysis
Samples were prepared with concentrations ranging from normal to abnormal. Urine was collected into I mL of 10% Merthiolate. Unused fresh frozen plasma from the Glasgow Royal Infirmary Blood Bank was used to prepare plasma samples. Dilutions were made using blank urine or plasma.
Urinary xylose
A volunteer took 25 g of xylose dissolved in 250mL of water. Urine was collected for the next 5 h. Aliquots of this urine were further diluted ( x 3 and x 6).
Plasma xylose 250 ILL of 2·5 moljL xylose solution was added to 250 mL of fresh frozen plasma (containing 0·1 mL of 75% Merthiolate) to produce a plasma concentration of 2·5 mmoljL. Two further dilutions were made to give plasma concentrations of 1·67 and 0·71 mmoljL xylose.
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Urinary laxative Three volunteers swallowed one tablet of Senokot (7'5mg of sennoside), 10mg of pure bisacodyl or two Alophen pills (30 mg aloin and 60 mg phenolphthalein) at bedtime and collected urine for the next 24 h. These are within recommended dosages.
Urinary PABA
A volunteer took 2'336mmol PABA (equivalent to the standard dose of I g N-benzoyl-L-tyrosylp-aminobenzoic acid for the PABA test) and urine was collected for the following 6 h. Aliquots of this urine were further diluted (x 1·5 and x 2,25).
Urinary fluorescein
A volunteer took an oral dose of 124mg fluorescein suspended in water and urine was collected over the next 12h. This sample representing the control day, was distributed at three dilutions (x 1-43, x 2·86 and x 5,71) to enable three pancreolauryl test results (TjK ratios; the percentage ratio of urinary fluorescein excretion on test and control days) to be calculated.
14C scintillation counting
An ethanolic solution of 14C-xylose was diluted with ethanol to produce approximately 110 000 dpmj5 mL. This represented a standard solution and further ethanolic dilutions (x 50, x 83·3 and x 250) were made. A volume of 5 mL of each solution was added to separate glass liquid scintillation vials and the ethanol allowed to evaporate. Blank samples were prepared in the same way using 5 mL ethanol. Laboratories were asked to add scintillation fluid and measure the radioactivity. Subsequently, blank values were subtracted and ratios of the dilutions to the standard solution were calculated to represent 14C breath test results.
Plasma fat
Four plasma samples representing a basal and three post-fat meal samples were distributed to enable three fat load test results to be calculated.
Duodenaljuice trypsin and bicarbonate
Duodenal juice was collected during two routine Lundh test procedures that gave normal and low results. One sample was spiked with sodium bicarbonate to increase the bicarbonate concentration by approximately 40 mmoljL. Equal quantities of these two samples were mixed to produce the third sample.
Intestinal disaccharidase
Small intestine homogenates were prepared using mucosal cells from rat intestine (sacrificed as part of a research study) and from two patients following partial ileal resections.
Faecal microscopy
Faeces were collected following a dual isotope fat absorption test,2 which is the test of intestinal absorptive capacity currently in routine use in Glasgow Royal Infirmary. These samples gave fat absorption results of 99%, 92% and 76% and were chosen to represent normal fat absorption (normal > 95%) and mild and moderate fat malabsorption, respectively. Faecal collections from routine tests were aliquoted to produce samples for analysis of faecal fat, faecal rz-l-antitrypsin and faecal chymotrypsin/trypsin.
Samples were stored at -18°C until distribution. Sample containers were wrapped in sufficient wadding to absorb their contents in the event of breakage, enclosed in plastic protective enclosures and then sealable plastic bags and sent by first class post in padded envelopes. Samples for measurement of disaccharidase enzymes, bicarbonate and trypsin in duodenal juice, faecal chymotrypsin and faecal rz-l-antitrypsin were packed in dry ice and sent by courier.
Questionnaire analysis
Details of all questionnaires returned were entered into a customized database. When relevant, results of measured analytes were converted into molar concentrations and any necessary calculations made (for example, calculation of pancreolauryl test results, plasma fat load test results). The mean, SD and coefficient of variation (CV) were calculated.
Results outwith ± 3 SD were excluded and the mean, SD and CV recalculated. When the number of results was small or the distribution of results was non-Gaussian, the mid-points and distribution of results were expressed as medians and interquartile ranges (lQR). When samples contained a known concentration of analyte, the percentage bias was calculated. Results of faecal rz-l-antitrypsin, faecal chymotrypsin, intestinal disaccharidase activities and fat meal tests were also expressed as a ratio of the individual laboratory's cut-off reference limit. This enabled Ann Clin Biochem 1998: 35 comparison of the degree of normality or abnormality of these results; for example, a ratio of two indicates a result twice the cut-off reference limit.
Many laboratories did not interpret faecal microscopy results and so, where possible, an interpretation was made on the basis of the microscopic description: an interpretation of malabsorption or normal absorption was based on the presence or absence of fat globules, respectively.
RESULTS
Response rates
Completed initial questionnaires were received from 186 departments (67%) within 182 hospitals, increasing to 236 (85%) departments within 231 hospitals after a reminder letter. Twelve of the departments contacted were in children's hospitals, of which ten replied.
Follow-up questionnaires were sent to 246 laboratories, with responses from 177 (72%), which increased to 233 (95%) after a reminder letter. The overall return of individual follow-up questionnaires was lower (70%) because several questionnaires were usually sent to each laboratory but not all were necessarily returned.
Completed questionnaires were initially received from 218 clinicians (55%), which rose to 330 (83%) after a reminder letter.
Repertoire and availability of GI tests
The availability and use by gastroenterologists of GI tests included in the survey is shown in Table 1 . Most of these analyses are provided within clinical biochemistry departments, although some are predominantly carried out in other hospital departments; for example, 62% of 14C-scintillation counting is carried out in medical physics departments and 82% of hydrogen breath tests are carried out III gastroenterology units.
The majority of tests (73%) in which timed specimens are collected (xylose absorption test, 14C breath tests, hydrogen breath tests, etc.) are performed in specialist settings (GI units, endoscopy units, multidisciplinary investigation units). Very few such tests are carried out in biochemistry departments (3%).
Analyses for most tests are provided on site, although 43 of 106 laboratories offering tests for laxative abuse send the samples away for analysis. Significant numbers of laboratories also send samples away for faecal chymotrypsin and :x-antitrypsin and for intestinal disaccharidase analysis.
Number of test requests
The number of requests received by laboratories for each of the GI investigations is typically very low ( 
Analytical performance
Inter-laboratory comparisons of analytical performance are shown in Table 3 , except for tests reported qualitatively. Wide analytical variation was found for faecal fat, plasma xylose, plasma turbidity, faecal :x-I-antitrypsin, duodenal juice trypsin and intestinal disaccharidase enzymes. Fig. I gives an example of the distribution of faecal fat and plasma xylose results. Analytes which showed broadly acceptable inter-laboratory reproducibility were urinary fluorescein, urinary PABA, 14C and urinary xylose. For xylose analysis in urine and plasma there was a large positive bias with both p-bromoaniline and phloroglucinol methods. There was also a positive bias for T/K ratios in urinary fluorescein analysis. There was a systematic bias for faecal fat analysis (positive or negative bias of > I SD for each of the samples measured) in 23% of laboratories. The qualitative faecal microscopy results also revealed a lack of analytical consensus. Using the dual isotope fat absorption method as the gold standard, 86% of results were falsely negative in a patient with mild malabsorption, while 64% of results were falsely negative in a poorly controlled coeliac patient with subtotal villous atrophy and a significant degree of malabsorption. Results in a sample from a patient with normal absorption gave a false positive rate of 36%. On the basis of these measurements, the overall sensitivity and specificity of faecal microscopy in UK laboratories is 26% and 64%, respectively. Analytical performance of urinary laxative screens showed a significant rate of false positive (7%) and false negative results (53%). Laxative analyses were performed either by thin-layer chromatography or alkalinization of the urine. The former method was more sensitive (false negative rate of 46% compared with 84% for alkalinization methods) but at the expense of poorer specificity (false positive rate of 8% compared to 0% for alkalinization methods).
An additional source of poor laboratory performance was the unexpected number of blunders discovered. On 13 occasions, the results of analysed samples were substantially different Ann Clin Biochem \998: 35 from the consensus or known values. Ten were due to mistakes in the calculations. For the other three, the laboratories could find no cause for the apparent discrepancy. The blunders were associated with 2 of 49 faecal fat analyses (4%), 6 of 39 urinary xylose analyses (15%) and 2 of 10 urinary PABA analyses (20%).
Reference ranges
Most (91%) laboratories quote reference ranges which have been taken from published articles ( Table 4 ). In general, wide variations in reference ranges were found between laboratories. One reason for this is the lack of uniformity of published reference ranges even when protocols are apparently similar. However, it is clear that some laboratories use reference ranges which are not traceable to the literature and presumably these represent erroneous transfer of reference ranges or incorrect completion of the questionnaire. The commonest misquote, made by 17% of laboratories, is the .. TABLE percentage of clinicians despite strong cases having been made for its withdrawal from routine use.>-7 The very poor analytical performance demonstrated from this survey srengthens that view. Of the four most widely available tests, only the pancreolauryl test shows acceptable interlaboratory reproducibility, with the use of a common reference range and protocol. Wide and unacceptable variations in cut-off levels and protocols were reported for xylose and lactose absorption tests.
Continued
Most laboratories carry out GI tests so infrequently that there is little opportunity to develop analytical expertise. In such circumstances it is likely that analytical quality will be compromised, even if well-worked methods and standard operating procedures are in place. The low request rate also limits opportunities for clinicians and laboratory staff alike to develop a good working experience of these tests. Table 2 also shows the enormous variation in the numbers of tests performed by different laboratories. It is difficult to explain this observation by differing catchment populations or referral patterns alone, since only laxative analyses are centralized to regional laboratories to a significant extent. It is more likely that this reflects variations in the perceived role of these investigations by clinicians and/or laboratory consultants.
Other possible reasons for the poor analytical performance of many of the analytes considered in the survey could be the infrequent use of quality control, the use of complex manual procedures by relatively inexperienced staff and the use of outdated or inappropriate methods. Of the laboratories surveyed, 71 % use no internal quality control procedures for GI analyses. The proportion of laboratories using internal quality control for individual tests is shown in Table 3 . Since conducting this survey, a pilot National External Quality Assessment Scheme (NEQAS) has been established for unnary laxatives, urinary fluorescein and urinary PABA. However, in the absence of external quality assurance programmes, the analytical validity of most GI tests remains unknown.
Most of the analytical methods employ manual techniques, several of which involve multiple steps. Such methodology often requires a level of technical expertise which, given the limited use of such tests, may be lacking in many laboratories. There was, in general, good agreement between the laboratory information on test availability and clinicians' views on their use of tests (Table  I) . However, although 72% of laboratories continue to offer the xylose absorption test, it is used by only 39% of gastroenterologists. In our view, laboratories should withdraw this test from their repertoire. The availability of alternative tests where necessary, the poor analytical performance and the ease with which endoscopic biopsies can be carried out all reinforce the view of Sladen and Kumar" that the test serves little purpose in routine practice. Faecal fat analysis is still offered by over 70% of laboratories and is used by a similar use of 1.3 mrnol/L as the lower limit of normal for plasma xylose (5 g xylose test protocol for adults with plasma measurement at I h). This figure is in fact the upper limit of normal.' ·Expressed as rnmol stearic acid/day. "Corrected to 1·73 rrr' body surface area. T/K = percentage ratio of urinary fluorescein excretion on test and control days; PABA = p-aminobenzoic acid; PEl = pancreatic excretion index.
For thin-layer chromatography of laxatives and for faecal microscopy, the analytical endpoints involve visual examination. Since this is largely a subjective measurement, results may vary if different staff carry out the analysis." The faecal microscopy questionnaire revealed that in only a minority of laboratories (34%) is the test usually or always performed by the same member of staff. Varying interpretations by staff may contribute to the poor analytical performance found for this procedure, especially as internal quality control is only performed by 21% of laboratories.
In view of the poor overall performance of laxative analysis, a follow-up questionnaire covering methodology was sent to the relevant laboratories to assess whether a systematic problem could be found. This revealed no apparent method-related causes, but visual examination of the plate may be a cause of misclassification of samples.
Analytical performance is ultimately dependent on the quality of the method used. However, several instances were found of outdated and inappropriate methods in current use. The majority of laboratories (59% for blood xylose, 66% for urinary xylose) measure xylose using a 1948 method." Misgivings about this method were highlighted in 1969. 10 Neither of these Ann Clin Biochem 1998: 35 methods are appropriate for the measurement of xylose in blood. An alternative spectrophotometric method using phloroglucinol was published in 1979 11 which, as well as being simpler, gives superior analytical reliability. Despite their improved analytical quality, these newer methods have not been widely adopted: 4% of laboratories use the 1969 modification to the p-bromoaniline method and about a quarter of laboratories use the phloroglucinol method. Table 3 shows that the phloroglucinol method performed better in the samples sent for analysis, with superior reproducibility between laboratories and improved accuracy. This improvement in precision and accuracy is in keeping with a previous evaluation of this method.F If laboratories or clinicians are unwilling to abandon the xylose absorption test, then an appropriate analytical method must be used.
Faecal microscopy has been evaluated by several groups with the almost invariable conclusion that it is a reliable means of detecting fat malabsorption. sou 17 The poor analytical performance of faecal microscopy presently found in the UK laboratories is clearly at odds with this literature evidence. However, the method generally used by UK laboratories differs from that reported in most publications. With the exception of one early paper.!' all reported evaluations of faecal microscopy measured neutral fat globules (triglyceride) and split fat globules (unesterified fatty acids). In contrast, most UK laboratories (86%) use procedures which only detect neutral fat globules. Only 7% of laboratories measure neutral and split fat globules. It has been demonstrated that failure to detect split fat will result in considerable false negative results.14.1b.17 A further example of the continuing use of an outdated method is the measurement of faecal trypsin as a pancreatic function test by nine laboratories. Faecal chymotrypsin is used by most laboratories in preference to faecal trypsin and is a better indicator of pancreatic dysfunction since the latter is susceptible to digestion during its transit through the gut. 18 The survey showed wide variations in reference ranges between laboratories. With the problems of establishing locally derived reference ranges for GI tests, the practice of transcribing them from publications is understandable. However, this practice is only appropriate if the analytical method is also transferable. The wide analytical variations observed between laboratories indicates that this is not the case for most tests, consequently most laboratories are currently using unvalidated reference ranges. From some GI investigations where considerable variation exists between laboratories on protocols, reference ranges, method used and even analyte measured, interlaboratory comparisons of analytical results offered an incomplete picture. For these tests, i.e. fat meal tests, faecal rx-I-antitrypsin, intestinal disaccharidase activities and faecal chymotrypsin/trypsin, an interpretation of the analytical result as normal or abnormal was made by referring to the laboratory's own quoted reference range. As Table 5 shows, for most of these tests there was no consensus on whether the results were normal or abnormal. The variation in the multiples of the reference cut-offs gives more information on the degree of comparability between laboratories. It is apparent that there were, on occasions, very marked discrepancies between laboratories. Laboratory results varied from clearly normal to markedly abnormal on the same samples. In some cases, variations of up to lO-fold in the degree of abormality of results were noted.
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Most GI investigations involve the use of test protocols specifying patient preparation, dose of substrate and timing of sample collections. For most tests, several protocols are in current use in UK laboratories; for some, the number of different protocols in current use exceeds the number published in the literature. For example, 16 different protocols for the plasma xylose absorption test were identified and 17 for fat load tests. All nine responders to 14C-triolein breath test questionnaires used different protocols. The variation may be due to incorrect transfer of the protocol or subsequent modification. Some of these protocols deviate significantly from published versions and as a result are probably invalid. Examples of such protocols are the use of 60 g or more of fat in the test meal for 14C-triolein breath tests, a single 30 min post-meal plasma collection in fat meal tests, and final collection times of 30 min or less in the lactose breath hydrogen test.
As with analytical methods, modifications to optimize protocols are rarely in use. For example, use of capillary rather than venous blood gives fewer false positive results in the lactose absorption test,'? but this protocol is used in only 14% of laboratories. Similarly, it is well known that in the protocol for quantitative faecal fat measurement the patient should consume at least 50 g per day of dietary fat and that care should be taken to ensure that faecal collections are complete. Despite the inevitability of false negative results in patients taking insufficient fat in the diet, only a minority of laboratories control (20%) or retrospectively assess (8%) fat intake. Where it is controlled there are wide variations in the amount of fat given (from 50 to 100 g per day) and how long it is given for. It is also essential that patients actually consume the dietary fat requirement; however, only one of the laboratories in which the dietary fat was controlled obtained feedback from the ward on the patient's consumption of fat. With regard to completeness of timed faecal collections, there is a suspicion in most laboratories (88%) that faecal collections may be incomplete, but only a minority of laboratories (8%) use faecal markers to correct for this.
Some GI investigations are inappropriate in certain categories of patient but the relevant patient exclusions are commonly not made. For example, five of the nine laboratories (54%) which perform the 14C-triolein breath test use it in inappropriate patient groups (patients with liver disease, diabetics and obese patients), and approximately a quarter of laboratories perform 
CONCLUSION
This survey has demonstrated serious deficiencies in the laboratory-based GI investigation service currently provided. A wide diversity of tests are in use across the country, reflecting a lack of consensus between gastroenterologists, chemical pathologists and biochemists on the most appropriate tests for investigating GI disorders. The current lack of consensus in practice is perhaps not surprising given the confusing choice of tests described in the literature and the sometimes conflicting evaluations published. This is exemplified by the fact that no single preferred test of malabsorption or pancreatic function has emerged from the considerable number described and probably indicates either limited diagnostic efficacies or practical difficulties in performing such tests. These inherent weaknesses are compounded in practice by the finding in this survey that protocols and reference ranges vary widely, and are sometimes unevaluated. In addition, overall analytical reliability was poor, suggesting that analytical quality may also be compromised.
Preliminary guidelines on the use of laboratory tests for malabsorption, with recommendations based largely on data from this audit, have been prepared by the British Society of Gastroenterology," and relevant committees of the Association of Clinical Biochemists and the British Society of Gastroenterology will jointly be seeking to develop more detailed recommendations on this complex subject. In the meantime the following easily implementable measures may improve the laboratory service: Clearly, urgent improvements are required; we hope that the results of this survey will stimulate colleagues to review their current practices as the first step in a process of updating and improving laboratory GI investigations.
